Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS. (Q44836524)
scientific article published on 8 April 2004
Language:
(P31) (Q13442814)
(P50) (Q66764444)
(Q87373605)
(Q89187648)
(Q88449379)
(Q103405750)
(Q117236316)
(Q117236339)
(Q122694370)
(P304) 857-864
(P407) (Q1860)
(P433) 3
(P478) 104
(P577) Thursday, April 8, 2004
(P921) (Q274160)
(Q323936)
(P1433) (Q885070)
(P1476) "Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS." (language: en)
(P2093) Marcos de Lima
Daniel Couriel
Xuemei Wang
Timothy Madden
James A Russell
Borje S Andersson
other details
description scientific article published on 8 April 2004

External Links